CEACAM1 and obesity disorder: That obesity and hepatic steatohepatitis are associated with impaired insulin clearance is demonstrated by the repression of hepatic CEACAM1 expression by high-fat (HF) intake [134] via a peroxisome-proliferator-activated receptor α (PPARα)-dependent mechanism [135].